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Key Element Pre Post
1. Is date time of Infusion Complete ? 84% 98%
Abstracts / Biol Blood Marrow Transplant 19 (2013) S167eS177 S171Future: These good clinical practices are leading to error
reduction and increased data validity. Our objective for the
2016 audit is to demonstrate below 1% total errors and attain
reciprocal data between electronic medical records, internal
databases, and CIBMTR by implementing one innovative
process per quarter.2. Is use of Hydration and Premedications indicated
(time of premeds) ?
68% 100%
3. Is Adverse Events completed ? 74% 100%
4. Is product type and cell dose complete ? 72% 95%
5. Is form signed by and Attending ? 95% 94%
6. Is the Start and Stop times completed ? 78% 98%
7. Are the vital sings completed per policy ? 67% 59%
Overall Results 77% 92%TRANSPLANT NURSING-ADMINISTRATION ORAL
112
Implementation of an Electronic Form for Hematopoietic
Stem Cell Transplant (HSCT) Infusions Improves
Documentation Compliance
Karen Collum. Nursing, Memorial Sloan - Kettering Cancer
Center, New York, NY
Background: Historically, Hematopoietic Stem Cell (HSC)
Infusionwas documented on a standard paper form available
from a document library throughout the institution. Once
complete, the form remained in the patient's chart until
discharge at which time the chart was scanned into the EMR.
This limited the availability and portability of the informa-
tion. Completion of this form was the responsibility of the
clinician infusing the HSC product. Additionally, HSC infu-
sions are conducted in a variety of units throughout MSKCC.
These areas have been divided into 5 major groups.
The Bone Marrow Transplant Quality Assessment
Committee (BMT QAC) conducted a compliance audit of
infusion documentation. The timeframe used for the audit
was October 2010 through March 2011, which included
a total of 194 transplants. A random selection of 50 trans-
plants (10 from each major group) during this 6 month
period was reviewed; resulting in a total of 60 forms (10 of
which were double cord transplants requiring 2 forms).
Seven key elements of the form were identiﬁed based on
regulatory and institutional requirements and audited for
completeness. The results of the audit indicated that docu-
mentation compliance was 77%.
Intervention: To improve documentation compliance of HSC
Infusions, we developed an electronic infusion form. The
building and testing of the form lasted approximately one
year. Simultaneously, we modiﬁed our vital sign monitoring
parameters for better standardization between different cell
types. During this time period, infusion Standard Operating
Procedure (SOP) was revised to incorporate use of the elec-
tronic document and standardized vital sign parameters. The
design of the electronic form required all ﬁelds to be
complete prior to ﬁnal electronic signature and acceptance of
the form. Additionally, Infusion vitals entered into the elec-
tronic ﬂowsheet by the RN were imported into the note by
the documenting clinician. Subsequent to distribution of the
SOP and training of Stem Cell Transplant service (Physicians,
Nurse Practitioners, Registered Nurses and Cell Processing
Technicians) the form went live in March 2012. Three weeks
post roll out to all areas, the paper form was removed from
the document library; however the form will be available
during system downtime.
Outcome: A follow up audit was conducted to measure
compliance post implementation of electronic documenta-
tion. The timeframe for the audit was April 2012 through July
2012, a total of 209 transplants. Similar to the pre-imple-
mentation audit, a random selection of 50 transplants from
the 5 major groups during this 4 month period were
reviewed for a total of 60 forms. The same 7 key elements of
the form were audited for completeness. The results of the
post implementation audit indicated that compliance ofdocumentation improved from 77% to 92%, an improvement
of 15%.113
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The System Capacity Initiative (SCI), sponsored by the
National Marrow Donor Program (NMDP), was convened to
evaluate and provide recommendations for addressing
workforce and infrastructure challenges for current and
future utilization of blood andmarrow transplant (BMT). The
Nursing Workforce Group (NWG) was established to address
projected shortages of BMT nurses. After surveying BMT
nurses, the NWG identiﬁed several priority challenges,
including the recruitment of nurses to the BMT ﬁeld. In an
effort to increase the number of BMT nurses, an outreach
presentation entitled ‘Introduction to BMT' was developed
and delivered to nursing students throughout the U.S. The
one-hour presentation describes the BMT process, identiﬁes
various nursing roles in BMT, and describes the beneﬁts of
working in this area. A brief pre and post survey is admin-
istered to assess the students' change in awareness of BMTas
a career option, nursing career preferences, likelihood of
pursuing a BMT career, and previous education/training in
BMT after listening to the presentation. To date, the presen-
tation, and pre and post surveys, was delivered to a total of
181 nursing students. The majority of students had not
previously considered a career in BMT (56.9%). However, the
presentation signiﬁcantly increased nursing students'
interest in pursuing a BMT career (N¼61; P < .0001). Addi-
tionally, students' indicated that ‘feeling valued' (62.5%),
‘intellectual stimulation' (66.3%), ‘emotional gratiﬁcation of
providing patient care' (69.5%) and ‘interest in subject
matter' (69.5%) were very important career aspects (see
Figure 1). The NWG in partnership with Oncology Nursing
Society (ONS) and American Society for Blood and Marrow
Transplantation (ASBMT) is continuing to promote the
presentation to increase awareness of BMT nursing as
a career option. It will be available for professional
